Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.

Guo-Ying LiuYan-Fang YeYao-Fei JiangGina Jinna ChenWei-Xiong XiaYi-Sheng HuangTian-Sheng GaoYi-Min LiuYa-Ting HouJian-Fei LiJia-Hao LiuNian LuChang-Long ChenLiang-Ru KeHu LiangWei-Xin BeiWang-Zhong LiShu-Hui DongQin LiuChangqing XieHe-Rui YaoYan-Qun Xiang

Published in: BMJ (Clinical research ed.) (2024)

Chinese Clinical Trial Registry ChiCTR1900027112.

Keyphrases

clinical trial
locally advanced
open label
phase iii
squamous cell carcinoma
double blind
phase ii
phase ii study
rectal cancer
study protocol
small cell lung cancer
radiation therapy
advanced non small cell lung cancer
placebo controlled
chemotherapy induced
randomized controlled trial
tyrosine kinase